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Abstract
Bacteria are ubiquitous throughout the environment, the most abundant inhabitants of the healthy human microbiome,
and causal pathogens in a variety of diseases. Their identification in disease is often an essential step in rapid diagnosis and
targeted intervention, particularly in clinical settings. At present, clinical bacterial detection and discrimination is primarily
culture-based, requiring both time and microbiological expertise, especially for bacteria that are not easily cultivated.
Higher-throughput molecular methods based on PCR amplification or, recently, microarrays are reaching the clinic as well.
However, these methods are currently restricted to a small set of microbes or based on conserved phylogenetic markers
such as the 16S rRNA gene, which are difficult to resolve at the species or strain levels. Here, we designed and
experimentally validated the BactoChip, an oligonucleotide microarray for bacterial detection and quantification. The chip
allows the culture-independent identification of bacterial species, also determining their relative abundances in complex
communities as occur in the commensal microbiota or in clinical settings. The microarray successfully distinguished among
bacterial species from 21 different genera using 60-mer probes targeting a novel set of in silico identified high-resolution
marker genes. The BactoChip additionally proved accurate in determining species-level relative abundances over a 100-fold
dynamic range in complex bacterial communities and with a low limit of detection (0.1%). In combination with the
continually increasing number of sequenced bacterial genomes, future iterations of the technology could enable to highly
accurate clinically-oriented tools for rapid assessment of bacterial community composition and relative abundances.
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Introduction
Modern molecular and metagenomic methods have given new
life to the problem of microbial detection, either singly or in
communities, and it remains a challenge in a wide variety of
contexts: pathogen detection in the clinic [1,2], surveys both of
host-associated microbiota [3,4] and of environmental communi-
ties [5], and microbial forensics [6], to name only a few. Bacteria
represent the majority of most such microbial communities [3,7],
but detecting specific bacteria can present a challenge; culture-
based methods are applicable to only a small fraction of bacteria
[8], and sequence-based methods targeting marker genes such as
the 16S rRNA often lack phylogenetic resolution [9,10]. This
raises further issues, as many microbes of interest including
Staphylococcus aureus [11], Escherichia coli [12], or Mycobacterium spp.
[13] have a pathogenic potential only at the species or strain level.
An opportunity thus exists for methods bridging the cost-
effectiveness and specificity of culture-based microbial quantifica-
tion with the breadth and throughput of modern sequence-based
techniques. Bacterial culture typically identifies microbial clades
within a sample based on phenotypic (morphological or biochem-
ical) features [14,15]. The earliest methods of bacterial species
detection were culture-based, and these techniques continue to
dominate clinical screens to this day [16]. While these techniques
have been highly optimized for a selection of common organisms
of interest, they are difficult to generalize. They can be applied
only to bacteria which are cultivable in vitro, and in cases where no
pre-existing standard protocol is available, optimizing new culture
conditions can be time-consuming and laborious to derive [17].
A variety of molecular methods are now also employed in
clinical laboratories, which can in many cases elucidate microbial
community composition at a much higher resolution than culture-
based methods [18]. These include real-time quantitative PCR
(qPCR), multiplex PCR, microarray and high-throughput se-
quence based techniques. Both qPCR and multiplex-PCR
represent rapid and simple methods to detect a small panel of
target bacteria in a complex mixture by amplification of species-
specific DNA regions. However, even multiplex PCR typically
scales only to detection of dozens of microbes simultaneously, and
clinical PCR-based tests are prone to amplification biases, false
positive detections, and erroneous quantification of relative
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bacteria in a complex mixture would thus require a broad panel of
qPCR probes, drastically increasing the costs and time required
for the analysis.
Conversely, although high-throughput sequencing techniques
for microbial identification have as yet to reach the clinic, they are
being employed in metagenomic research [20]. Like PCR, they
often target specific taxonomic marker genes, usually the 16S
rRNA gene [20,21]. Amplification and sequencing of such genes
from a complex sample using ‘‘universal’’ primers can simulta-
neously quantify most bacteria in a community, although again
with phylogenetic resolution limited to approximately the genus
level [21]. Most recently, shotgun metagenomic sequencing has
become practical for surveying an entire community’s metage-
nomic [22], but this is neither a practical method for simple
microbial quantification nor yet feasible in a clinical setting [23].
Phylogenetically targeted microarrays have been successfully
proposed as a means to bridge the gap between throughput, cost,
and clinical feasibility [24]. In contrast to PCR and DNA
sequencing methods, the microarray format for microbial com-
munity characterization permits the quantification of a broad
panel of microbes maintaining low cost per sample. Some microbe
detection arrays developed to date have been designed with short
probes (e.g. 25-mers) tiled to perfectly match target genes flexibly
spanning multiple species of interest (e.g. the prototype Respira-
tory Pathogen Microarray RPM v1.1 [25]). Chips adopting short
oligonucleotide probes may guarantee almost no cross-hybridiza-
tion events, but present a lower sensitivity [26], thus requiring a
pre-amplification step of the microbial DNA and again precluding
quantification.
Microbe and microbial function detection arrays designed with
longer probes (e.g. 60-mer) have been applied both for environ-
mental microbes (e.g. PhyloChip [27], GeoChip [28]) and for
host-associated bacteria (e.g. GreenChip [29], HOMIM [18],
HITChip [7]). These arrays all currently target a combination of
known functional classes genes or, most commonly, variants of the
single 16S rRNA gene. Importantly, longer probes for the
taxonomically well-studied 16S rRNA gene typically show higher
sensitivity than short probes, but this incurs low resolution due to
cross-hybridization of similar sequences across taxa. This has been
specifically reported to cause over-estimation of community
richness [30], since the highly conserved 16S rRNA gene often
fails to discriminate below the genus level for many clades [24].
Taxonomic identification with such chips can therefore require
complex bioinformatic postprocessing to avoid copy number or
cross-hybridization biases, and even in the best case the species- or
strain-level resolution needed for pathogen detection is precluded.
We have thus designed the BactoChip to simultaneously
address issues of sensitivity, specificity, and cost in microbial
detection microarrays, aiming to render them feasible for very
high-throughput, low cost-per-sample microbiome studies in
human cohorts. First, we designed long probes targeting clade-
specific marker genes by assembling a catalog of markers unique
to 54 bacteria of medical interest drawn from all available
microbial genomes. We then experimentally validated a custom
oligonucleotide microarray using 57- to 60-mer hybridization
probes targeting these genes. The array, termed the BactoChip,
showed high performance in identifying the presence of single
organisms at the species level, even among mixtures of multiple
species from the same genus. Additionally, it proved able to
quantify the relative abundances of these species in mixed
communities over a 100-fold range and with a limit of detection
below 0.1% in abundance. The Bactochip thus provides the
potential to detect and quantify microbial species and strains
with higher accuracy and throughput than available methods,
particularly as future revisions of the chip scale to include
additional sequenced genomes. The sensitivity of detection
demonstrated by this study may prove applicable both for rapid,
cost-effective detection in the clinic and for further investigations
of the human microbiome and other complex microbial
communities.
Results
Design of Species-specific Marker Probes for the
BactoChip
We developed an oligonucleotide microarray to simultaneously
identify a broad range of bacterial species with clinical relevance to
human health. In contrast to current phylogenetic microarray
approaches for microbial identification, which target individual
universally conserved genes such as the 16S rRNA, we identified in
silico those genes that most unequivocally characterized each
bacterial species. Unique, conserved regions within these genes
were subsequently targeted for microarray probe design (Figure 1).
Specifically, for the 37 experimentally tested species reported
in Table 1 (of 54 total included in the initial probe design), we
identified nucleotide-coding sequences strongly conserved
($99% identity in most cases) among genomes within each
species (see Methods). Such genes were considered ‘‘core’’ for
each species; we subsequently identified the subset of core genes
without substantial similarity (no local matches with e-value
lower than 1e-5) to any genomic sequence outside the target
species, making them specific to that species. The initially small
number of targeted species was limited by available genome
sequence and strain accessibility at the time of chip design, and
the bioinformatic approach employed is applicable to any
broader set of sequenced bacterial genomes. The first step in
design thus considers all genomes available for each species of
interest, whereas the latter employs all sequenced bacterial and
archaeal genomes. When selecting among candidate genes for
microarray probe design, unique genes with the greatest copy
numbers and sequence lengths were prioritized, in order to
maximize detection sensitivity and facilitate probe subsequence
selection, respectively. This step resulted in 340 genes being
targeted from among 37 testable species chosen from 900
available finished genomes. Hybridization probes were designed
for biophysical consistency and compatibility by means of the
Allele ID software (Premier Biosoft International, Palo Alto, CA,
USA), which accounts for hybridization efficiency and avoids
potential cross-hybridization. Our microarray design is provided
at the Array Express Repository with accession number A-
MEXP-2138, and data for all arrays, run during these
experiments, is provided with accession E-MEXP-3420.
The number of species-specific markers varied considerably
across the bacterial kingdom, reflecting the phylogenetic
diversity of each species, their genome sizes, pan- versus core
genomes, and degree of functional specialization [31]. For
example, the high similarity of the Escherichia and Shigella genera
limited the number of genes distinguishing individual species to
at most 50. Staphylococcus species, on the other hand, were
instead more diverged, with a minimum within the genus of
281 markers for S. aureus and a maximum of 847 for S.
saprophyticus. The highest numbers of unique species-character-
izing genes were detected for Bacteroides, with 1,236, 1,702, and
1,952 genes for B. fragilis, B. vulgatus, and B. thetaiotaomicron,
respectively. Among more than 30,000 unique marker genes
identified for the 54 bacterial species during design (see
Materials and methods and ArrayExpress database, experiment
The BactoChip Microarray
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microarray probes, resulting in a total of 2,094 57/60-mer
probes (with three technical replicates each per chip), an
average of 1166140 probes for each species, and 3.662.7
distinct probes for each marker gene. 520 probes passed quality
control for the 37 species of interest, with an average of
6.962.6 marker genes for each species (min 1 for S. haemolyticus,
max 10 for several species) and 2.061.6 probes per gene
(Table 1).
A characterization of these marker genes based on high-level
Cluster of Orthologous Groups of proteins (COGs) [32]
included selections from all top-level pathways (Figure S1).
BactoChip-targeted genes were under-enriched for uncharacter-
ized proteins not matching any COG category, and conversely
overrepresented ‘‘replication, recombination and repair’’ genes
(COG L) compared to the total distribution in available
genomes (14% against 4%). These two functional categories
varied most from the background of all genomes, with most
other functional categories demonstrating an even selection
among BactoChip probes. Additional analysis with targeted
functional databases determined that 19.97% of the markers are
virulence factors (as defined by VFDB 2012 [33,34]), and
4.99% are involved in antibiotic resistance (as define by ARDB
[35]). This large fraction of pathogenicity-related genes is
consistent with the pathogenic phenotype of most of the
targeted species in the BactoChip and with the species-
specificity of virulence genes.
The BactoChip Correctly Identifies 37 Clinically Relevant
Bacteria at the Species Level
As an initial validation, microbial samples each containing DNA
from a single bacterial isolate were prepared for 37 randomly
chosen species with available strains, from among the 54 bacterial
species included during array design. Genomic DNA was either
purchased from the german collection of microorganisms and cell
cultures (DSMZ, from Deutsche Sammlung von Mikroorganismen
und Zellkulturen GmbH) (Leibniz Institute DSMZ, Braunschweig,
Germany) or extracted from microbial isolates; these were
obtained from LGC Standards American Type Culture Collection
(ATCC) (Manassas, VA, USA) and DSMZ catalog strains as
vacuum dried cultures or from the Hospital Santa Chiara (Trento,
Italy) as actively growing cells. The identity of hospital isolates
from this study was confirmed by 16S rRNA gene sequencing
(Table S1). Both types of microbial samples were prepared for the
BactoChip by chemical labeling with the Universal Linkage
System (ULS) linked to the Cy3 fluorophore (Agilent Technolo-
gies, Santa Clara, CA, USA). As shown in Figure 2, most
individual BactoChip probes (red) and nearly all postprocessed
aggregate species abundances (green) were determined to provide
accurate assessments of microbial species.
Based on per-sample Areas Under the receiver operating
characteristic Curves (AUCs) for probe and aggregate intensities,
almost all species were perfectly identified. In all but five of 37
cases (13.5%), the preprocessed and normalized probes with the
highest intensities were exactly and only the probes designed for
Figure 1. Design of the BactoChip and its application for microbial species identification and quantification. (A) Schematic overview of
computational design and its output. (A1) Complete genomes from 186 bacterial species were retrieved from the National Centre for Biotechnology
Information microbial database. (A2) Gene sequences core to each target species were defined on the basis of sequence conservation within each
clade. Red dots represent the distribution of core genes shared by strains within and outside a target clade. (A3) Core genes unique to each target
species were selected by sequence alignment against all available archaeal and bacterial sequences. (A4) Oligonucleotide probes were designed for
up to 10 identified unique genes for each target bacterial species. Each probe color represents specificity to a defined bacterial species. (B)
Experimental design and example data. (B1) DNA from microbial communities was tested on the BactoChip. Green dots represent Cy3 bound to
genomic DNA fragments from a sample hybridized to the chip. (B2) Species relative abundances are finally inferred by normalization of the
fluorescence signal for each probe and species.
doi:10.1371/journal.pone.0055764.g001
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36 of 37 test species (97.3%) were perfectly identified (AUC
values higher than 0.99). This includes cases in which the
BactoChip continued to perform well even when a finished
genome for the specific isolate strain present in the sample was
unavailable (e.g. Acinetobacter baumanii, Klebsiella pneumonia, and
Staphylococcus carnosus).
Of the small fraction of individually malfunctioning probes,
only three represented false negatives, i.e. probes with no or low
signal for the intended target species, specifically Corynebacterium
efficiens, Micrococcus luteus and Pseudomonas mendocina. In these
cases, either the target gene was not in the core genome of the
tested strain as expected, or the specific 60-mer sequences
targeted by these probes (and by probes removed during
standard preprocessing) were affected by polymorphisms relative
to the sequenced reference genomes. Likewise, two sets of false
positive probes affected our validations (Figure 2): 1 probe for
Corynebacterium diphtheriae and Corynebacterium jeikeium and 20 for
Staphylococcus haemolyticus. These false positives, together with
completely inactive probes (never above the 95
th percentile and
removed during preprocessing), arose due to the limited number
of complete genomes available at the time of chip design,
leading to an overestimation of genes’ uniqueness to each
species (e.g. only 1 genome available for Listeria innocua). One of
the most notable of these, a probe designed for C. diphtheriae that
activated for Propionibacterium acnes, may be due to a horizontal
gene transfer event that did not occur in the sequenced P. acnes
strain.
In all but one of these five examples, our overall microarray
design prevented these outliers from impacting species detection,
as it incorporates several probes per gene and several genes per
species. In fact, after computational postprocessing that included
inactive probe removal, gene copy number calibration, and
aggregation of all probes in each species, only one species
(Staphylococcus haemolyticus) remained below the maximum achiev-
able AUC. Overall, this extensive validation of the BactoChip with
single bacteria selected from more than two thirds of the chip’s
current targets demonstrated high accuracy in identifying the
individual bacterial species.
The Abundances of Multiple Congeneric Bacterial
Species are Accurately Estimated within Mixed Samples
We next assessed the BactoChip’s ability to additionally
discriminate multiple mixed bacterial species within the same
genus. This is of particular interest for genera such as Staphylococcus
in which some species may be pathogenic and others commensal;
these are often poorly resolved by single 16S genes [36,37]. This
genus contains extremely diverse species found throughout the
human microbiome [38] and includes organisms of clinical interest
such as S. aureus. We thus tested the BactoChip on 6 species from
the clinically relevant staphylococci comprising S. aureus, S. carnosus,
S. epidermidis, S. haemolyticus, S. lugdunensis, and S. saprophyticus.
Hybridization of this mixed sample on the BactoChip resulted in
all six species being correctly identified (Figure 3).
When considering multiples species in a single sample, it is
important to identify both which species are present as well as their
relative abundances. Although some pathogens can cause infection
even when present at very low concentration, complex diseases
such as obesity or inflammatory bowel disease have been
connected with quantitative shifts in commensal bacterial com-
Table 1. BactoChip specifications for the 19 target genera used in this study.
Target Genera Target Species
Average (SD)
genes/species
Min – Max genes/
species
Average (SD)
probes/gene
Min – Max
probes/gene
Acinetobacter A. baumanii 9.0 (0.0) 9–9 1.0 (0.0) 1–1
Bacteroides B. fragilis, B. thetaiotaomicron, B. vulgatus 9.0 (0.8) 8–10 1.9 (1.7) 1–6
Citrobacter C. koseri, C. rodentium 8.0 (0.0) 8–8 2.4 (1.7) 1–6
Clostridium C. difficile, C. kluyveri, C. perfringens 6.7 (1.7) 5–9 1.8 (1.4) 1–5
Corynebacterium C. diphteriae, C. efficiens, C. jeikeium 8.0 (0.8) 7–9 2.4 (1.6) 1–6
Enterococcus E. faecalis 7.0 (0.0) 7–7 3.0 (1.9) 1–6
Escherichia E. coli, E. fergusonii 5.0 (2.0) 3–7 2.0 (1.1) 1–4
Haemophilus H. influenzae 9.0 (0.0) 9–9 1.0 (0.0) 1–1
Klebsiella K. pneumoniae 2.0 (0.0) 2–2 1.0 (0.0) 1–1
Listeria L. innocua, L. monocytogenes 7.0 (3.0) 4–10 1.9 (1.5) 1–6
Micrococcus M. luteus 6.0 (0.0) 6–6 2.0 (1.2) 1–4
Ochrobactrum O. anthropi 8.0 (0.0) 8–8 2.5 (1.4) 1–5
Propionibacterium P. acnes 6.0 (0.0) 6–6 3.8 (2.0) 1–6
Proteus P. mirabilis 7.0 (0.0) 7–7 2.6 (1.7) 1–5
Pseudomonas P. aeruginosa, P. fluorescens, P. mendocina, P.
putida
4.3 (2.9) 2–9 1.6 (1.2) 1–5
Salmonella S. enterica 9.0 (0.0) 9–9 2.3 (0.9) 1–4
Staphylococcus S. aureus, S. carnosus, S- epidermidis, S.
haemolyticus, S. lugdunensis, S. saprophyticus
7.3 (3.0) 1–10 2.4 (1.9) 1–6
Stenotrophomonas S. maltophilia 4.0 (0.0) 4–4 1.0 (0.0) 1–1
Streptococcus S. equi, S. pyogenes 9.0 (1.0) 8–10 1.1 (0.3) 1–2
The 19 tested target genera are listed here, together with a list of the species tested for each genus and the corresponding average number of target genes per species
and probes per gene tested in this study with the BactoChip.
doi:10.1371/journal.pone.0055764.t001
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tational postprocessing (see Methods), all relative abundances of
organisms were correctly estimated by the BactoChip within an
average deviation of 24%. Thus even within the genus Staphylo-
coccus along, mixed species could be measured reliably. The
proposed microarray was both able to accurately differentiate
among closely related species within a single sample and to
determine their relative abundances quantitatively to a high
degree of accuracy.
The BactoChip Enables Species-level Abundance
Quantification within Microbial Communities
We also extended our validation of samples containing
multiple species to mixed communities of up to 15 different
organisms belonging to 12 genera. Complex microbial commu-
nities are of increasing translational interest for analyses of the
human microbiome [41], which can require the simultaneous
quantification of up to hundreds of bacterial taxa. As a more
modest evaluation of this initial version of the BactoChip, we
designed two synthetic bacterial communities comprising 9 and
15 different species, respectively (Table S1). Each synthetic
community was prepared by mixing defined microbial DNA
species, as quantified by Nanodrop ND1000; the first commu-
nity comprised 9 species from 8 different genera, whereas the
second community 15 species from 12 different genera. We
tested four versions of each community comprising high (63.3–
146.8 ng) and low (6.3–14.7 ng) microbial DNA concentrations
at both evenly distributed and at staggered concentrations (up to
30-fold within-sample relative abundance differences among
species).
The BactoChip was able to correctly identify bacterial
presence and absence within these two communities with
Figure 2. Accurate detection of individual bacterial species using the BactoChip. Bar plot indicates the Areas Under the receiver operating
characteristic Curves (AUCs) for detection of 37 individual target species. Heatmap shows intensities of individual probes (red) and postprocessed
aggregate species quantification (green). Almost all tested species (94.6%) were identified unequivocally by the specifically designed oligonucleotide
probes, both based on raw data (see diagonal) and by comparing against the microbial gold standard (all AUC values .0.96).
doi:10.1371/journal.pone.0055764.g002
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estimated relative abundances closely approximated the expect-
ed community compositions. In the smaller of the two
communities, evenly distributed abundance estimations deviated
from reference values by less than 15% in half of the cases, the
worst result being an estimation of 3.9% of Acinetobacter baumanii
against an expected value of 7.7%. The staggered abundance
setting achieved similar results, with an overall correlation of
0.97 (p,10
210) of predicted values with reference. Even in the
larger community, microbial composition was correctly identi-
fied in each case, with only two outliers (Stenotrophomonas
maltophilia and Streptococcus pyogenes) in a formulation of the
community with staggered abundances; these were likely due to
a swapped sample label and were not considered in subsequent
experiments, as available resources precluded the possibility of
proving or disproving a mislabeling. For the evenly distributed
formulation of this community, all relative abundance estima-
tions were within at most two-fold of the expected value.
The BactoChip probe design and computational calibration can
thus continue to be developed to enable increasingly accurate
relative abundance quantification in more diverse communities
such as the human microbiome, although it would already be
appropriate for reduced-complexity samples (e.g. hospital surfaces
or clinical isolates [42]. However, we did observe only a small
effect of low (6.3–14.7 ng) microbial DNA concentration (root
mean squared error of 0.022 versus 0.027 for the first mix), which
would negatively impact the high-throughput sequencing ap-
proaches currently applicable to such diverse communities.
Likewise, these data confirm the BactoChip’s ability to detect
microbes as rare as 3% of a community, and its lower limit of
detection reached approximately two orders of magnitude smaller
(bounds lowered with the saliva microbiome samples detailed
below). Overall, in combination with the single-species and single-
genus experiments above, these evaluations show that the
BactoChip achieved near-perfect detection of bacterial species,
discriminated among species from the same genus, and could be
applied to microbiomes of modest complexity and with uneven
species concentrations to reliably estimate microbial community
composition.
The BactoChip Accurately Detects Changes in Absolute
Microbial Abundance in a Comparative Setting
Unlike sequencing-based approaches, which are limited to
assessing relative microbial abundances, the Bactochip proved
capable of accurately determining differences in absolute levels of
microbial abundance among samples. This proved true even of
species-level fold-change differences in multi-organism communi-
ties assayed on different arrays. Four formulations of the 9-species
community described above were assayed, two at even abundance
distributions and two staggered, both with different absolute DNA
concentrations. When contrasting absolute probe intensities for
organisms in the high and low concentration versions, as well as
the two staggered versions of this community, we detected a fold
change higher than 2.5 for all and only the expected species
(Table 2). The same level of detection held for the larger
community as well (Table 2), confirming that the BactoChip’s
ability to qualitatively assess absolute microbial load in a
comparative setting was robust within medium-complexity micro-
bial communities.
These fold change estimations between communities were
performed on absolute probe intensities, which in turn serve as a
proxy for absolute microbial concentrations. In a setting such as
this in which at least one between-arrays comparison is possible,
we can thus provide approximate information on both relative and
absolute microbial abundances within communities. This has yet
proven infeasible with other approaches such as shotgun or 16S-
rRNA sequencing, which provide only relative abundances, thus
limiting the interpretation of changes in community composition
among samples [43]. For example, a sequencing-based compar-
ison between the high and low concentration formulations of our
first community would produce no detectable differences after
conversion to relative abundances, despite a 10-fold variation in
number of microbial cells. Although further calibration will be
needed to make such determinations of absolute abundance more
quantitative, this evaluation demonstrates that the BactoChip is
capable of comparatively detecting absolute microbial abundances
in a manner not possible using high-throughput sequencing,
making it a flexible alternative for microbial assessment in case-
control investigations in addition to community composition
profiling.
Figure 3. Quantification of the relative abundances of multiple species from the same genus contained within a single sample. True
versus detected relative abundances for each of 6 Staphylococcus species are shown in blue (gold standard) and red (inferred), respectively. Even DNA
relative abundances were targeted, with true experimental abundances of cell copy numbers varying due to differences in genome size. Mean
Squared Error (MSE) of relative abundance over all predictions was below 0.0019.
doi:10.1371/journal.pone.0055764.g003
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Control Organisms in the Human Oral Microbiome
Finally, we applied the BactoChip to profile the oral micro-
biomes of two healthy subjects. Saliva samples from two subjects
were extracted and hybridized with and without spike-ins of one to
three microbes present at relative abundances ranging from 10%
to 0.1% of total DNA. The chip’s quantification of species-level
hybridization intensities relative to the total microbial load (from
0.125 mg to 1.000 mg) was extremely linear across the assessed
concentration ranges (Figure 5A). This allowed us to select a target
of 0.250 mg of microbial DNA per sample for further experiments,
which is thus also a reasonable recommendation for future
microbial community studies on the BactoChip.
For both tested subjects, the BactoChip detected the native
presence of Streptococcus equi (.90%), Stenotrophomonas maltophilia,
Haemophylus influenzae, and Listeria innocua (Figure 5B). As the
BactoChip was designed to address almost exclusively pathogenic
microbes, most genera typically found in the healthy saliva
microbiome (as established by 16S sequencing on a large cohort
[44]) are in fact not currently targeted by the BactoChip, both by
design and due to the reduced panel of originally available
sequenced genomes. We thus augmented both subjects’ samples
with specific species over a range of concentrations with respect to
the original total bacterial load, which were both detected and
correctly quantified in all nine cases (Figure 5B). The correct
detection of Streptococcus pyogenes independently from other Strepto-
coccus spp. (specifically the phylogenetically close S. equi)i so f
particular interest, as it demonstrates the species-specificity of the
BactoChip and its robustness to cross-hybridization.
We compared the estimated abundances of spikes-in within and
across samples, and the expected fold change values were observed
for all eight intra-subject comparisons (Figure 5C). This within-
study normalization is necessary in this case since direct
quantitation of single spikes-in is precluded due to the unknown
fraction of the microbial community comprised by non-target
organisms. These organisms did also highlight, however, the
BactoChip’s ability to detect microbes as rare as 0.1% of the total
community at over a 100-fold dynamic range (for example,
S. aureus at 0.0016concentration, Figures 5B–C).
Figure 4. Accurate determination of microbial community composition of up to 15 species at even and staggered abundances. (A)
Bar plots show true (blue) versus predicted (red and green) relative abundances for a 9-species bacterial community with evenly distributed
abundances and high or low DNA concentrations. MSE of relative abundance over all predictions was below 0.0006. (B) True (blue) versus predicted
(red) abundances for a 15-species evenly distributed community, total MSE ,0.0013. (C) Evaluation of the BactoChip’s overall quantitation of relative
microbial abundances in all four staggered communities. Each point represents the predicted vs. true relative abundance for one species in one
experiment, with total R
2.0.75.
doi:10.1371/journal.pone.0055764.g004
Table 2. Detection of changes in absolute microbial load
among samples.
9-organism community Predicted fold-change
.2.5 ,2.5
Difference absolute
abundance
Yes 36 0
No 01 8
15-organism community Predicted fold-change
.2.5 ,2.5
Difference absolute
abundance
Yes 23 0
No 31 3
Evaluation of the predicted difference in absolute microbial abundance
(detected fold change larger then 2.5) with respect to the expected variations
for (A) the 9-species community and (B) the 15-species community.
doi:10.1371/journal.pone.0055764.t002
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Defining the composition of bacterial communities is important
for basic research, for microbial epidemiology, and for clinical
investigations. In order to realize both the throughput and
specificity of sequence-based techniques for microbial identifica-
tion, we created the BactoChip, an oligonucleotide microarray
targeting species-specific marker genes. In this initial study, the
BactoChip proved able to identify 37 species from 19 genera with
near-perfect accuracy, even in the presence of multiple species
from the same genus (e.g. for the clinically relevant Staphylococcus
genus). Moreover, in 7 complex communities of up to 15
organisms at 10-fold different relative abundances, the BactoChip
proved able to quantify relative abundances with high accuracy
(r=0.97, p,10
210). While these synthetic communities are
simpler than the thousands of organisms of the commensal human
microbiota [32], they serve as a proof-of-principle that the
BactoChip can scale from single pathogen detection to whole-
community characterization in a clinically accessible manner.
Previous work on microarrays for microbial quantification has
focused on the universal 16S rRNA gene, while the BactoChip
employs a novel in silico-driven selection of unique species-specific
marker genes. The 16S rRNA marker has a long history in DNA-
sequencing based microbial quantification, but even there poses
substantial challenges due to necessary amplification steps,
differing copy numbers among organisms, and, critically, a
frequent lack of resolution below the genus level [45]. Its use on
microarrays adds the complexity of cross-hybridization, as the 16S
sequence is, by definition as a ‘‘universal’’ marker, quite well-
conserved [46]. Conversely, we selected species-specific genes
guaranteed to be unique to targets of interest, within the limits of
currently available finished microbial genomes (now over 1,300),
which permits both greater detection accuracy and the opportu-
nity to investigate the evolutionary history of the selected genes.
Considerable variability was observed in the number of unique
sequences for each species, ranging from about 50 in E. coli (given
its genomic closeness to Shigella) to almost 2,000 in B.
thetaiotaomicron. This is not surprising, given the high stringency
of the conservation threshold (99%) chosen for maximizing
sequence conservation in this setting, the influences of intra-genus
and intra-species diversity, the number of available genomes for
the species considered, and the different rates of horizontal gene
transfer among clades [47]. In some cases, few marker genes were
available due to the large overlap of a species’ pan-genome with
the corresponding genus pan-genome (e.g. Listeria monocytogenes)o r
its overall sequence diversity (e.g. Stenotrophomonas maltophilia [48]).
In other cases, species-level core genes were readily available, but
they were only infrequently determined to be unique, as a
consequence of horizontal gene transfer events or of strong
conservation (e.g. the Enterobacteriaceae [49]). These features
were detected by our computational pipeline but they do not
impact the BactoChip itself.
The characteristics of the BactoChip compare favorably to
those of existing methods for clinically-oriented bacterial identi-
fication and quantification. While no high-throughput method can
compete with the current cost or standardization of single-
organism culture or amplification techniques, our approach has
clear advantages when fastidious microbes must be targeted.
Likewise it scales to quantify relative abundances of dozens or
potentially hundreds of organisms simultaneously, which is
impractical for culture- or PCR-based techniques and currently
unfeasible in clinical practice using high-throughput sequencing.
Figure 5. Application of the BactoChip to the oral microbiome detects native Streptococcus spp. and correctly identified the
introduced spike-in species. A) Species-level averaged intensities linearly correlate with the total measured DNA in the range 0.125–1.000 mg. B)
BactoChip detected the presence of Streptococcus equi in the saliva samples of both subjects at abundances higher than 50%. The introduced spike-
ins for five different species at different abundances (from about 0.1% to 10% of the total community) were successfully identified in all cases with
accurate distinction between different Streptococcus species. Only the species with a relative abundance greater than 1.5% in at least one sample are
reported. C) Quantitative evaluation of the predictions for the introduce spike-ins looking in terms of fold change between the abundances within
and between samples. All comparison showed strong consistency with the expected fold changes.
doi:10.1371/journal.pone.0055764.g005
The BactoChip Microarray
PLOS ONE | www.plosone.org 8 February 2013 | Volume 8 | Issue 2 | e55764Finally, these microarray results themselves are consistent with a
smaller study reporting identification of bacterial species specifi-
cally within the Enterobacteriaceae [49]. Since our approach is
scalable and limited only by the number and diversity of available
microbial genomes, it could be expanded from the species to the
strain level or used to target non-bacterial microbes (e.g. Fungi or
Archaea [50]). Moreover, this microarray platform seamlessly
permits the incorporation of functional marker sequences in
addition to taxonomic markers; for example, we anticipate
targeting a set of virulence factor genes in the next revision, thus
allowing the estimation of a sample’s pathogenic or antibiotic
potential in addition to its composition.
It is interesting to note that, while the BactoChip was
particularly useful in the clinically-relevant task of high-throughput
species-specific bacterial detection, it also showed promise in fully
quantifying relative abundances of microbes in mixed populations.
We piloted here 2 communities with 7 different configurations,
using both synthetically even and more physiological staggered
organismal abundances, with this first iteration of the BactoChip
achieving high precision with up to 15 organisms. In all of these
communities, our taxonomic marker genes proved to remain
specific down to the species level, with few errors in identification
and most imprecisions arising instead in the quantification of
relative abundance. Finally, BactoChip experiments on the human
saliva microbiome from two healthy subjects confirmed its
applicability to true high-complexity samples and suggested a
limit of detection at least as low as 0.1%.
Since 16S-based microarrays such as the PhyloChip, and
HITChip have proven quite successful in quantifying genus-level
relative abundances [18,51], we anticipate that we will be able to
further improve our precision in this task at the species-level using
targeted probe design, biophysical modeling for normalization,
and additional chip-level positive and negative controls in future
iterations of the microarray. In conclusion, this study’s novel
combination of in silico marker gene selection with microbial
species detection and quantification by microarray shows the
feasibility of the approach. We believe these tools will pave the way
for the further development of reliable and inexpensive micro-
array-based methods for culture-independent species-level micro-
bial screening, particularly in clinical settings.
Materials and Methods
The design and testing of the BactoChip consisted of two major
steps. In the first, we identified in silico species-specific genetic
markers and designed oligonucleotide probes for these genes. The
second step involved experimental assessment of this microarray
design, including the hybridization of DNA from reference
bacterial strains and clinical isolates.
In silico Design
Identification of species-specific marker genes. The
coding sequences of 186 annotated complete bacterial genomes
comprising 54 clinically relevant species were downloaded from
the National Centre for Biotechnology Information microbial
database (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi) as of
June 2010. We identified core genes with .99% similarity, if not
otherwise stated, within all complete genomes available for each of
the 54 species. This is a particularly stringent threshold adopted in
order to identify the most conserved genes at species level. We
then selected unique genes for each bacterial species, i.e. core
genes with no blastn hits to genomes outside the target species.
Few species (e.g. Listeria monocytogenes) showed low enough sequence
conservation to produce fewer than 10 core or unique genes; in
these cases, the similarity percentage required for core gene
selection was reduced to 80% to increase the number of candidates
(otherwise prioritized identically with respect to intra-species
conservation). Since this had the potential to increase the false
negative rate due to reduced affinity in DNA probe hybridization,
we chose multiple marker genes for such species to counteract
potential false assignments due to higher false negative rate.
We functionally profiled the unique markers by mapping them
against COGs [32] sequences using BLASTP (e-value threshold
,1e–5 with best hit policy). The resulting distribution of top-level
functional categories was compared to that of a baseline obtained
by profiling all Integrated Microbial Genomes database [52]
genes. Similarly, we tested the presence of virulence factors and
antibiotic resistance genes using comparable mappings to the
VFDB 2012 [33,34] and ARDB [35] databases respectively.
Probe selection for unique genes. Oligonucleotide probes
were designed using the AlleleID software version 7.01 (Premier
Biosoft Int., Palo Alto, CA, USA). The probes consisted of 57- to
60–mers with similar physicochemical parameters (GC.40%,
Tm=73uC65uC). Probes were selected according to the number
of hits with 100% identity within the target bacterial species. To
ensure reliable identification of the intended bacteria, probes
targeting an average of 6.962.6 unique-genes were designed for
each bacterial species (see Table 1 for probes passing subsequent
quality control). The full set of probe IDs, sequences and target
unique-gene are shown at ArrayExpress database (www.ebi.ac.uk/
arrayexpress) with accession number E-MEXP-3420.
Microarray design. Custom microarrays with the designed
oligonucleotide probes were purchased from Agilent-Technologies
(Santa Clara, CA, USA) using the ‘‘custom high-definition Agilent
DNA Comparative Genomic Hybridization arrays 8615 k’’. This
format is suitable to this study’s goal of microbiome-wide profiling
of DNA copy number changes associated with microbial agents.
The custom microarray comprised 2,094 marker gene probes, 87
internal controls from Agilent or added during design, 140 Agilent
negative controls, 49 Agilent dark corners and 2898 additional
probes targeting genes of functional interest. For each marker gene
probe three technical replicates were randomly distributed on the
chip (see ArrayExpress database, experiment E-MEXP-3420).
Bacterial and clinical sample collection. Bacterial collec-
tion included 37 target species belonging to 19 genera, chosen for
their high prevalence in hospital settings and the availability of
annotated complete genomic sequences as of June 2010. 1–2 off-
target species were selected for assessment within each bacterial
genus. Strains for each species were purchased when available as
vacuum dried culture or DNA from the LGC Standards ATCC
and the Leibniz Institute DSMZ. Others were collected as actively
growing cultures clonally isolated on blood-agar media from
clinical specimens at the Microbiology and Virology Unit (Santa
Chiara Hospital, Trento, Italy). Gold standard strains used for
experimental evaluation of the microarray are described in the
supplemental data (Table S1). Clinical isolates were identified at
the hospital by routine culture-based methods and confirmed by
16S rRNA gene sequencing.
Clinical samples were obtained from 2 healthy subjects who
received oral hygiene instructions and gave their informed
consent. Up to 15 mL saliva samples were collected from the 2
subjects by non-stimulated drooling into sterile plastic tubes.
Samples were processed within 2 hours from the collection time as
previously described [53].
Experimental Design
Total DNA isolation. High-purity total bacterial DNA was
extracted with silica-based DNA purification QIAGEN DNeasy
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eluted in 200 mL sterile distilled water. DNA quality was assessed
by agarose gel electrophoresis after staining with ethidium
bromide, whereas DNA purity and concentration was determined
by measuring absorbance at 230, 260, and 280 nm with the
Nanodrop ND1000 (NanoDrop products, Wilmington, DE, USA).
Total DNA from saliva samples was extracted as previously
described [52] and purified with the QIAGEN DNeasy Blood&-
Tissue kit as for pure bacterial cultures.
Quantification of bacterial DNA in saliva samples. The
bacterial load in saliva samples was determined by amplification
and detection of the 16S rRNA gene by real-time PCR, performed
with the CFX96 real-time PCR detection system (Bio-Rad
Laboratories S.r.l., Milan, Italy), using optical grade 96-well
plates. The PCR reaction was performed in a 25 mL final volume
using 2.5 mL of 2X QuantiTect SYBR Green mix (Qiagen S.r.l.,
Milan, Italy), 3 mL template DNA and 0.5 uM of each of the
universal primers: forward primer, 59-TCCTACGGGAGGCAG-
CAGT-39 and reverse primer, 59-GGACTACCAGGGTATC-
TAATCCTGTT-39 [54]. The PCR protocol comprised an initial
denaturation at 95uC for 10 min, 40 cycles of 95uC 15 sec, 60uC
20 sec, 72uC 40 sec and a melting curve analysis from 65uCt o
95uC and fluorophore detection at last step of each cycle.
Escherichia coli DNA from ATCC25922 strain was used as a
standard for determining the absolute quantification of saliva
samples with or without a spiked-in bacterial DNA at known
concentration. Quantified values for saliva samples were corrected
taking in account the difference in amplification efficiency between
E. coli known quantity and the same spiked in saliva samples.
DNA labeling. Total DNA was fragmented for 3 min at
95uC and chemically labelled with the ULS linked to the Cy3
fluorophore, as described in the Genomic DNA analysis ULS
Labeling Kit manual (Agilent Technologies, Santa Clara, CA,
USA).
Microarray hybridization. Labelled samples, resuspended
in hybridization cocktail, were hybridized to the custom micro-
array according to the manufacturer’s instruction manual (Agilent
Technologies, Santa Clara, CA, USA). Microarrays were tested
with single or multiple labelled targets. An overview of all
experiments performed is presented as supplemental data (Table
S1 and ArrayExpress database, accession number E-MEXP-3420).
Image acquisition and data processing. Images were
acquired with the DNA Microarray Scanner G2505C and the
ScanControl software; data were extracted with the Feature
Extraction software v10.7 using the Agilent one-colour gene
expression protocol GE1_107_Sep09 (Agilent Technologies, Santa
Clara, CA, USA). Raw and processed data are provided at
ArrayExpress database, experiment E-MEXP-3420.
Computational postprocessing. Probe signal intensities
were determined by subtracting the local background values (as
estimated by the Agilent platform) from the per-sample median.
Each probe’s three technical replicates were then averaged and a
robust average (obtained removing values above the 95
th
percentile and below the 5
th percentile) of all probes in the same
species was performed. Species relative abundances were then
estimated by relativizing this species average with respect to the
sum of all averages. Unsupervised probe selection was performed
by removing probes never showing signal above the 98
th percentile
(false negative removal) or always above median in more than 75%
of samples (aspecific false positive removal). Calibration for multi-
species experiments was performed using single-species experi-
ments first by normalizing each probe’s signal with respect to the
concentration of genomes in the sample, estimated by transform-
ing DNA concentrations to genome concentrations by dividing by
the average genome length of sequenced strains within each
species. Finally, positive probes below a 100x fold change with
respect to the median of the negative probe distribution were
removed for noise reduction.
Supporting Information
Figure S1 BactoChip markers represent all high-level
functional areas within available genomes. Yellow bars
represent the fraction of BactoChip marker genes in each top-level
functional category from the COG database, red the fractions
from all genomes included in the Integrated Microbial Genomes
database is also reported as a reference background distribution.
Most fractions are comparable, with the BactoChip underenriched
for uncharacterized proteins and overenriched for housekeeping
DNA maintenance and structural proteins.
(EPS)
Figure S2 Quantification of composition of 9-species
and 15-species full communities, in staggered concen-
trations. Bar plots show real versus predicted relative abun-
dances in red and blue, respectively.
(EPS)
Table S1 List of experiments performed in this study.
The 61 experiments on 37 species and saliva samples are listed
here, with specifications on the experiment ID, the bacterial
species tested and its strain ID, supply format and collection source
reference. In the last two columns, the DNA quantity, as estimated
by Nanodrop ND1000, and corresponding array ID are provided.
(DOCX)
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